tirzepatide kidney damage Mounjaro seems good for protection in those with type 2 #diabetes, as expected. The benefits appear greater for those with kidney disease Data from Apperloo EM, et al. Diabetes Care. 2025;doi:10.2337/dc24-1773 Tirzepatide and Kidney Disease: Safety

About 1 in 8 Americans uses GLP-1 drugs for diabetes, weight loss and other chronic conditions, including semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound)

Find a location near you today!

While weight loss varies from person to person, clinical studies suggest that patients using semaglutide can lose an average of 15% of their body weight over the course of a year

Purity & Documentation Data Sheet (276 KB) SDS (393 KB) English - EN (393 KB) Franais - FR (393 KB) Deutsch - DE (393 KB) Norwegian - NO (393 KB) Espaol - ES (393 KB) Swedish - SV (393 KB) Italian - IT (393 KB) Korean - KR (393 KB) Portuguese - PT (393 KB) Handling Instructions (2659 KB) References [1]

This can be especially beneficial for acne scars, sun-damaged areas, or skin recovering from cosmetic treatments

Sources All retatrutide trials ClinicalTrials.gov Lilly Trial Finder Eli Lilly TRIUMPH trial design paper Diabetes, Obesity and Metabolism Related reading Retatrutide FDA Approval Timeline 2026-2028 Lilly plans a Q1 2027 BLA filing